Log in
NASDAQ:PAVM

PAVmed Stock Forecast, Price & News

$1.96
0.00 (0.00 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.92
Now: $1.96
$2.00
50-Day Range
$1.73
MA: $1.88
$2.04
52-Week Range
$0.81
Now: $1.96
$3.45
Volume335,010 shs
Average Volume914,715 shs
Market Capitalization$102.42 million
P/E RatioN/A
Dividend YieldN/A
Beta0.02
PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.
Read More
PAVmed logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.22 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PAVM
CUSIPN/A
Phone212-949-4319
Employees15

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.18) per share

Profitability

Net Income$-16,460,000.00

Miscellaneous

Market Cap$102.42 million
Next Earnings Date4/8/2021 (Estimated)
OptionableNot Optionable
$1.96
0.00 (0.00 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PAVM News and Ratings via Email

Sign-up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PAVmed (NASDAQ:PAVM) Frequently Asked Questions

How has PAVmed's stock price been impacted by COVID-19 (Coronavirus)?

PAVmed's stock was trading at $1.74 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PAVM shares have increased by 12.6% and is now trading at $1.96.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of PAVmed?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PAVmed in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for PAVmed
.

What stocks does MarketBeat like better than PAVmed?

Wall Street analysts have given PAVmed a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but PAVmed wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is PAVmed's next earnings date?

PAVmed is scheduled to release its next quarterly earnings announcement on Thursday, April 8th 2021.
View our earnings forecast for PAVmed
.

How were PAVmed's earnings last quarter?

PAVmed Inc. (NASDAQ:PAVM) posted its earnings results on Tuesday, November, 17th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by $0.01.
View PAVmed's earnings history
.

What price target have analysts set for PAVM?

3 brokers have issued 12-month price objectives for PAVmed's shares. Their forecasts range from $5.00 to $5.00. On average, they anticipate PAVmed's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 155.1% from the stock's current price.
View analysts' price targets for PAVmed
.

Who are some of PAVmed's key competitors?

What other stocks do shareholders of PAVmed own?

Who are PAVmed's key executives?

PAVmed's management team includes the following people:
  • Dr. Lishan Aklog M.D., Chairman & CEO (Age 54, Pay $677.85k)
  • Mr. Dennis M. McGrath C.P.A., Pres, CFO & Corp. Sec. (Age 63, Pay $517.5k)
  • Dr. Brian J. deGuzman M.D., Chief Medical Officer & Exec. VP of Clinical Affairs (Age 55, Pay $455.31k)
  • Mike Havrilla, Director of Investor Relations
  • Mr. Shaun M. O'Neil, Chief Commercial Officer

What is PAVmed's stock symbol?

PAVmed trades on the NASDAQ under the ticker symbol "PAVM."

Who are PAVmed's major shareholders?

PAVmed's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.53%), State Street Corp (0.83%), Vigilare Wealth Management (0.31%), AQR Capital Management LLC (0.16%), First Wilshire Securities Management Inc. (0.10%) and CIBC Private Wealth Group LLC (0.07%). Company insiders that own PAVmed stock include Dennis M Mcgrath, Lishan Aklog and Matthew Sirovich.
View institutional ownership trends for PAVmed
.

Which major investors are selling PAVmed stock?

PAVM stock was sold by a variety of institutional investors in the last quarter, including Jane Street Group LLC, and JPMorgan Chase & Co..
View insider buying and selling activity for PAVmed
.

Which major investors are buying PAVmed stock?

PAVM stock was acquired by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, State Street Corp, First Wilshire Securities Management Inc., BlackRock Inc., CIBC Private Wealth Group LLC, Vigilare Wealth Management, Financial Advocates Investment Management, and Squarepoint Ops LLC. Company insiders that have bought PAVmed stock in the last two years include Dennis M Mcgrath, and Lishan Aklog.
View insider buying and selling activity for PAVmed
.

How do I buy shares of PAVmed?

Shares of PAVM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is PAVmed's stock price today?

One share of PAVM stock can currently be purchased for approximately $1.96.

How big of a company is PAVmed?

PAVmed has a market capitalization of $102.42 million. PAVmed employs 15 workers across the globe.

What is PAVmed's official website?

The official website for PAVmed is www.pavmed.com.

How can I contact PAVmed?

PAVmed's mailing address is ONE GRAND CENTRAL PLACE SUITE 4600, NEW YORK NY, 10165. The company can be reached via phone at 212-949-4319 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.